Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline

Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline

<p><strong>Introduction:</strong> Less-invasive surfactant administration (LISA) is a method of surfactant delivery to preterm infants for treating respiratory distress syndrome (RDS), which can reduce the composite risk of death or bronchopulmonary dysplasia and the time on mechan...

Descrición completa

Detalles Bibliográficos
Main Authors:	Reynolds, P, Bustani, P, Darby, C, Fernandez Alvarez, JR, Fox, G, Jones, S, Robertson, SJ, Vasu, V, Roehr, CC
Formato:	Journal article
Idioma:	English
Publicado:	Karger Publishers 2021

Títulos similares

Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress
por: Ramaswamy, VV, et al.
Publicado: (2021)

Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress syndrome treated with noninvasive respiratory support
por: Ramaswamy, VV, et al.
Publicado: (2021)

To sedate or not to sedate for less invasive surfactant administration: an ethical approach
por: Peterson, J, et al.
Publicado: (2021)

Curriculum and assessment tool for less invasive surfactant administration: an international Delphi consensus study
por: Breindahl, N, et al.
Publicado: (2023)

Guidelines for the use of lung ultrasound to optimise the management of neonatal respiratory distress: international expert consensus
por: Jing Liu, et al.
Publicado: (2025-02-01)

Efficacy of non‐invasive respiratory support modes for primary respiratory support in preterm neonates with Respiratory Distress Syndrome: Systematic review and network meta‐analysis
por: Ramaswamy, VV, et al.
Publicado: (2020)

Surfactant Apoprotein D in Preterm Neonates with Acute Respiratory Distress Syndrome
por: S. A. Perepelitsa, et al.
Publicado: (2009-10-01)

The Effects of Antenatal Corticosteroids and Surfactant Replacement on Neonatal Respiratory Distress Syndrome
por: Suada Heljić, et al.
Publicado: (2009-08-01)

Surfactant and respiratory distress syndrome
por: A D Milner
Publicado: (1996-01-01)

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress
por: Anna Tarocco, et al.
Publicado: (2015-01-01)

Exogenous surfactant transport through the pulmonary airways : improving surfactant replacement therapy for neonatal respiratory distress syndrome
por: Espinosa, Frank F. (Frank Francis)
Publicado: (2005)

Corrigendum to “Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress”
por: Anna Tarocco, et al.
Publicado: (2015-01-01)

Effects of Exogenous Surfactants on the Parameters of Blood Gas Composition in Neonatal Respiratory Distress Syndrome
por: S. A. Perepelitsa, et al.
Publicado: (2007-06-01)

Replacement Therapy with the Surfactant Alveofact for Neonatal Respiratory Distress Syndrome: A Pilot Study
por: S. A. Perepelitsa
Publicado: (2014-08-01)

Management of respiratory distress syndrome in moderate/late preterm neonates: A Delphi consensus
por: Segundo Rite Gracia, et al.
Publicado: (2024-11-01)

Outcomes Comparison of Early versus Late Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome
por: Chutinun Wongkhonkaen, et al.
Publicado: (2023-05-01)

Clinical efficacy of using pulmonary surfactant at different times in the treatment of neonatal respiratory distress syndrome
por: ZHU Ling, et al.
Publicado: (2023-12-01)

An uncommon cause of neonatal respiratory distress
por: Gabriel Dimitriou, et al.
Publicado: (2010-12-01)

Significance of surfactant proteins in respiratory distress syndrome in preterm infants
por: İ.A. Mirzayeva, et al.
Publicado: (2024-04-01)

Exogenous surfactant therapy in non-respiratory distress syndrome
por: A Greenough
Publicado: (1996-01-01)

Surfactant BL-Induced Changes in Blood Gas Composition and Acid-Base Balance In Neonatal Respiratory Distress Syndrome
por: S. A. Perepelitsa, et al.
Publicado: (2006-08-01)

Laryngeal Mask Airway Method for Minimally Invasive Surfactant Therapy in Neonates with Pneumothorax Complicating Respiratory Distress Syndrome
por: Joaquim M. B. Pinheiro, et al.
Publicado: (2025-01-01)

Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis
por: Moschino, L, et al.
Publicado: (2022)

Surfactant as a drug carrier
por: Sett, A, et al.
Publicado: (2023)

Comparison of the Consequences of Intratracheal Administration of Surfactant Plus Budesonide with Surfactant alone in Preterm Infants with Respiratory Distress Syndrome
por: Morteza Habibi, et al.
Publicado: (2024-01-01)

Guidelines on the management of acute respiratory distress syndrome
por: Danny Francis McAuley, et al.
Publicado: (2019-10-01)

The Outcomes of Preterm Infants with Neonatal Respiratory Distress Syndrome Treated by Minimally Invasive Surfactant Therapy and Non-Invasive Ventilation
por: Tzyy-Rong Huang, et al.
Publicado: (2024-04-01)

Respiratory Distress and the Bacteria Causing Infection in the Neonates
por: Neihaya Heikmat Zaki
Publicado: (2012-06-01)

Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome
por: Nilgün Köksal, et al.
Publicado: (2009-12-01)

Management of neonates with respiratory distress syndrome in resource-limited settings
por: Radhika Singh, et al.
Publicado: (2024-05-01)

INSURE method (INtubation-SURfactant-Extubation) in early and late premature neonates with respiratory distress: factors affecting the outcome and survival rate
por: Ali Naseh, et al.
Publicado: (2014-06-01)

Construction and evaluation of neonatal respiratory failure risk prediction model for neonatal respiratory distress syndrome
por: Yupeng Lei, et al.
Publicado: (2024-01-01)

Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond
por: Ozge Sürmeli-Onay, et al.
Publicado: (2012-06-01)

Exogenous Surfactant Therapy for Pediatric Patients with Acute Respiratory Distress Syndrome
por: James F Lewis, et al.
Publicado: (1997-01-01)

Use of Surfactant-BL in Adult Patients with Acute Respiratory Distress Syndrome
por: A. V. Vlasenko, et al.
Publicado: (2005-12-01)

Surfactant Protein D Is a Biomarker of Acute Respiratory Distress Syndrome
por: V. V. Moroz, et al.
Publicado: (2013-08-01)

The association between sex and neonatal respiratory distress syndrome
por: Keren Fang, et al.
Publicado: (2024-02-01)

Influence of catheter thickness on respiratory physiology during less invasive surfactant administration in extremely preterm infants
por: Chamindu C. Gunatilaka, et al.
Publicado: (2024-09-01)

Pulmonary insufficiency of extreme prematurity (PIEP) and surfactant deficiency disease (SDD) – It is time to classify respiratory distress syndrome (RDS) in preterm neonates
por: Deepti Thandaveshwara, et al.
Publicado: (2024-04-01)

Comparing the Effects of Two Surfactant Administration Methods: Minimally Invasive Surfactant Therapy (MIST) with Intubation (INSURE) in Infants with Respiratory Distress Syndrome
por: Hassan Boskabadi, et al.
Publicado: (2024-10-01)